News and information about prostate cancer
Preliminary results from a University of Toronto study indicate that androgen deprivation therapy (ADT) does not affect most cognitive domains, and may even be associated with a slight improvement in some areas of cognitive function.
This prospective study examined changes in cognitive function over time in three groups of men who were matched for...
Results were reported in 2002 on 231 patients with favourable-risk prostate cancer (Gleason score 6 or less, PSA 10 or under) who were part of a prospective phase II trial of active surveillance that began in 1995 at the Sunnybrook Health Sciences Centre in Toronto, Ontario. The present study was based on the second analysis of this group, which now...
The value of statins (medications used to lower cholesterol levels) to reduce the risk of advanced prostate cancer, as well as to lower PSA levels in men without prostate cancer, is controversial. This study looked at the association of statin use and biochemical (PSA) recurrence after radical prostatectomy.
The study examined evidence from a...